Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Semsarian, C
This phenomenon may be explained by alterations in hormonal secretion induced by bariatric surgery (108, 109)
VESPER-1 VESPER-1 was a 28-week randomized, double-blind, placebo-controlled trial that assessed the efficacy and safety of once-weekly berobenatide across a range of dose levels (0.4 to 1.2 mg) in adults with obesity or overweight with hypertension and/or dyslipidemia
Gradients in bone morphogenetic protein-related gene expression across the growth plate
US$ 24.84
US$ 22.82
US$ 22.51
US$ 23.37
